Drugmakers pin hopes on new private research body

Published: 2013-08-08 06:56:00

Updated: 2013-08-08 06:56:00

The new private consultative body, which has been sought by the Korea Drug Research Association (KDRA) in May, has drawn keen interest from the industry as the body will play a pivotal role to spur the long-term growth of research and development (R&D) oriented companies .

KDRA officials said ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK